vs

Side-by-side financial comparison of CB Financial Services, Inc. (CBFV) and Invivyd, Inc. (IVVD). Click either name above to swap in a different company.

Invivyd, Inc. is the larger business by last-quarter revenue ($17.2M vs $13.8M, roughly 1.2× CB Financial Services, Inc.). On growth, Invivyd, Inc. posted the faster year-over-year revenue change (24.5% vs 19.9%).

CB Bank is one of Myanmar's largest commercial banks. It became the first bank in Myanmar to issue ATM cards and credit cards. The bank, led by U Khin Maung Aye (Chairman) and U Kyaw Thu Ko (CEO) has over 245 branches across the country.

Invivyd, Inc. is a clinical-stage biopharmaceutical company focused on developing broadly neutralizing antibody therapies to prevent and treat serious viral infectious diseases. Its core research and development pipeline targets high-burden respiratory pathogens including respiratory syncytial virus, catering to unmet medical needs of global patient groups.

CBFV vs IVVD — Head-to-Head

Bigger by revenue
IVVD
IVVD
1.2× larger
IVVD
$17.2M
$13.8M
CBFV
Growing faster (revenue YoY)
IVVD
IVVD
+4.6% gap
IVVD
24.5%
19.9%
CBFV

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CBFV
CBFV
IVVD
IVVD
Revenue
$13.8M
$17.2M
Net Profit
$-11.1M
Gross Margin
Operating Margin
38.1%
-73.0%
Net Margin
-64.3%
Revenue YoY
19.9%
24.5%
Net Profit YoY
40.0%
EPS (diluted)
$0.90
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CBFV
CBFV
IVVD
IVVD
Q4 25
$13.8M
$17.2M
Q3 25
$2.4M
$13.1M
Q2 25
$13.5M
$11.8M
Q1 25
$12.1M
$11.3M
Q4 24
$13.2M
$13.8M
Q3 24
$12.7M
$9.3M
Q2 24
$12.2M
$2.3M
Q1 24
$13.5M
$0
Net Profit
CBFV
CBFV
IVVD
IVVD
Q4 25
$-11.1M
Q3 25
$-5.7M
$-10.5M
Q2 25
$3.9M
$-14.7M
Q1 25
$1.9M
$-16.3M
Q4 24
$-18.4M
Q3 24
$3.2M
$-60.7M
Q2 24
$2.6M
$-47.2M
Q1 24
$4.2M
$-43.5M
Operating Margin
CBFV
CBFV
IVVD
IVVD
Q4 25
38.1%
-73.0%
Q3 25
-289.8%
-84.0%
Q2 25
35.0%
-127.8%
Q1 25
19.3%
-149.7%
Q4 24
23.1%
-139.1%
Q3 24
31.2%
-670.0%
Q2 24
26.4%
-2175.2%
Q1 24
37.9%
Net Margin
CBFV
CBFV
IVVD
IVVD
Q4 25
-64.3%
Q3 25
-235.2%
-79.7%
Q2 25
29.3%
-124.4%
Q1 25
15.8%
-144.1%
Q4 24
-133.5%
Q3 24
25.3%
-653.1%
Q2 24
21.8%
-2086.9%
Q1 24
31.1%
EPS (diluted)
CBFV
CBFV
IVVD
IVVD
Q4 25
$0.90
$0.02
Q3 25
$-1.07
$-0.06
Q2 25
$0.74
$-0.12
Q1 25
$0.35
$-0.14
Q4 24
$0.45
$-0.14
Q3 24
$0.60
$-0.51
Q2 24
$0.51
$-0.40
Q1 24
$0.82
$-0.38

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CBFV
CBFV
IVVD
IVVD
Cash + ST InvestmentsLiquidity on hand
$31.7M
$226.7M
Total DebtLower is stronger
Stockholders' EquityBook value
$157.5M
$241.5M
Total Assets
$1.5B
$276.9M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CBFV
CBFV
IVVD
IVVD
Q4 25
$31.7M
$226.7M
Q3 25
$55.9M
$85.0M
Q2 25
$64.5M
$34.9M
Q1 25
$61.3M
$48.1M
Q4 24
$49.6M
$69.3M
Q3 24
$147.3M
$106.9M
Q2 24
$142.6M
$147.9M
Q1 24
$73.7M
$189.4M
Stockholders' Equity
CBFV
CBFV
IVVD
IVVD
Q4 25
$157.5M
$241.5M
Q3 25
$152.5M
$93.1M
Q2 25
$148.4M
$42.8M
Q1 25
$148.3M
$54.1M
Q4 24
$147.4M
$67.5M
Q3 24
$149.1M
$83.2M
Q2 24
$142.9M
$140.6M
Q1 24
$141.6M
$178.5M
Total Assets
CBFV
CBFV
IVVD
IVVD
Q4 25
$1.5B
$276.9M
Q3 25
$1.5B
$139.2M
Q2 25
$1.5B
$89.1M
Q1 25
$1.5B
$103.7M
Q4 24
$1.5B
$129.5M
Q3 24
$1.6B
$161.9M
Q2 24
$1.6B
$177.3M
Q1 24
$1.5B
$215.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CBFV
CBFV
IVVD
IVVD
Operating Cash FlowLast quarter
$17.8M
$-15.5M
Free Cash FlowOCF − Capex
$17.2M
FCF MarginFCF / Revenue
124.1%
Capex IntensityCapex / Revenue
4.7%
0.0%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$29.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CBFV
CBFV
IVVD
IVVD
Q4 25
$17.8M
$-15.5M
Q3 25
$4.6M
$-8.3M
Q2 25
$4.1M
$-13.3M
Q1 25
$4.0M
$-21.1M
Q4 24
$6.8M
$-37.6M
Q3 24
$3.1M
$-41.1M
Q2 24
$-1.2M
$-41.6M
Q1 24
$3.3M
$-50.2M
Free Cash Flow
CBFV
CBFV
IVVD
IVVD
Q4 25
$17.2M
Q3 25
$4.5M
Q2 25
$3.9M
$-13.3M
Q1 25
$3.9M
$-21.3M
Q4 24
$3.4M
$-37.6M
Q3 24
$2.2M
$-41.1M
Q2 24
$-2.4M
Q1 24
$2.3M
$-50.4M
FCF Margin
CBFV
CBFV
IVVD
IVVD
Q4 25
124.1%
Q3 25
186.5%
Q2 25
28.8%
-112.9%
Q1 25
32.5%
-188.2%
Q4 24
26.0%
-272.2%
Q3 24
17.4%
-441.6%
Q2 24
-19.6%
Q1 24
17.0%
Capex Intensity
CBFV
CBFV
IVVD
IVVD
Q4 25
4.7%
0.0%
Q3 25
4.3%
0.0%
Q2 25
1.9%
0.1%
Q1 25
0.8%
1.3%
Q4 24
25.1%
0.0%
Q3 24
6.7%
0.1%
Q2 24
10.0%
0.0%
Q1 24
7.2%
Cash Conversion
CBFV
CBFV
IVVD
IVVD
Q4 25
Q3 25
Q2 25
1.05×
Q1 25
2.11×
Q4 24
Q3 24
0.95×
Q2 24
-0.44×
Q1 24
0.78×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons